Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. SPCX
7. AVGO
8. HD
9. BJ
10. BABA

Go back to Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
DYNEGY, Inc. (NASDAQ: DYN) Delayed: 26.10 +0.12 (0.46%)
Previous Close $25.98    52 Week High $22.01 
Open $26.22    52 Week Low $7.01 
Day High $26.87    P/E N/A 
Day Low $26.02    EPS $0.00 
Volume 1,181,848